tiprankstipranks
Keros Therapeutics (KROS)
NASDAQ:KROS
US Market

Keros Therapeutics (KROS) Technical Analysis

Compare
328 Followers

Technical Sentiment

Overall Consensus
Strong Sell
0Bullish
0Neutral
13Bearish
Technical Analysis Consensus
Strong Sell
0Bullish
0Neutral
1Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Keros Therapeutics’s (KROS) Moving Averages Convergence Divergence (MACD) indicator is -0.44, suggesting Keros Therapeutics is a Buy.
Keros Therapeutics’s (KROS) 20-Day exponential moving average is 10.93, while Keros Therapeutics’s (KROS) share price is $10.04, making it a Sell.
Keros Therapeutics’s (KROS) 50-Day exponential moving average is 13.80, while Keros Therapeutics’s (KROS) share price is $10.04, making it a Sell.

Keros Therapeutics (KROS) Pivot Points

Apr 03, 2025, 11:16 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
9.22
9.46
9.83
10.07
10.44
10.68
11.05
Fibonacci
9.46
9.70
9.84
10.07
10.31
10.45
10.68
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Keros Therapeutics (KROS) Moving Averages

Apr 03, 2025, 11:16 PM
Period
Simple
Exponential
MA5
10.31Sell
10.25Sell
MA10
10.80Sell
10.61Sell
MA20
11.15Sell
10.93Sell
MA50
11.10Sell
13.80Sell
MA100
24.80Sell
22.07Sell
MA200
38.31Sell
34.20Sell
Keros Therapeutics’s (KROS) 10-Day exponential moving average is 10.61, while Keros Therapeutics’s (KROS) share price is $10.04, making it a Sell.
Keros Therapeutics’s (KROS) 100-Day exponential moving average is 22.07, while Keros Therapeutics’s (KROS) share price is $10.04, making it a Sell.
Keros Therapeutics’s (KROS) stock price is $10.04 and Keros Therapeutics’s (KROS) 50-day simple moving average is 11.10, creating a Sell signal.
Keros Therapeutics’s (KROS) stock price is $10.04 and Keros Therapeutics’s (KROS) 100-day simple moving average is 24.80, creating a Sell signal.
Keros Therapeutics’s (KROS) stock price is $10.04 and Keros Therapeutics’s (KROS) 200-day simple moving average is 38.31, creating a Sell signal.

Keros Therapeutics (KROS) Technical Indicators

Apr 03, 2025, 11:16 PM
Name
Value
Implied Action
RSI (14)
26.61
Buy
STOCH (9,6)
16.88
Buy
STOCHRSI (14)
13.96
Buy
MACD (12,26)
-0.44
Buy
ADX (14)
20.07
Neutral
Williams %R
-94.47
Buy
CCI (14)
-272.61
Buy
ATR (14)
0.57
-
Ultimate Oscillator
41.81
Neutral
ROC
-12.47
Sell
Keros Therapeutics’s (KROS) Relative Strength Index (RSI) is 26.61, creating a Buy signal.
Keros Therapeutics’s (KROS) Trend Strength Indicator (ADX) is 20.07, creating a Neutral signal.
Keros Therapeutics’s (KROS) Commodity Channel Index (CCI) is -272.61, creating a Buy signal.
Keros Therapeutics’s (KROS) Price Rate of Change (ROC) is -12.47, creating a Sell signal.

FAQ

Is KROS a Buy, Hold, or Sell?
Based on KROS’s technical indicators, KROS is a Strong Sell.
    What is KROS’s RSI (14)?
    KROS’s RSI (14) is 26.61, which suggests KROS is a Buy.
      What is KROS’s MACD?
      KROS’s MACD is -0.44, which suggests KROS is a Buy.
        What is KROS’s 5-day moving average?
        KROS’s 5-day moving average is 10.31, which suggests KROS is a Sell.
          What is KROS’s 20-day moving average?
          KROS 20-day moving average is 11.15, which suggests KROS is a Sell.
            What is KROS’s 50-day moving average?
            KROS’s 50-day moving average is 11.10, which suggests KROS is a Sell.
              What is KROS’s 200-day moving average?
              KROS’s 200-day moving average is 38.31, which suggests KROS is a Sell.
                What is KROS’s Williams % R (14)?
                KROS’s Williams % R (14) is -94.47, which suggests KROS is a Buy.
                  What is KROS’s CCI (14)?
                  KROS’s CCI (14) is -272.61, which suggests KROS is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis